MedPath

Antispastic efficasy of l-menthol spray on the duodenal mucosa compared with intravenous administration of scopolamine butylbromide for endoscopic retrograde cholangiopancreatography (ERCP)

Not Applicable
Recruiting
Conditions
biliary tract disease
Registration Number
JPRN-UMIN000008101
Lead Sponsor
Kyoto prefectural Yosanoumi hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

age 20 years younger; severe heart disease; severe lung disease; prostatic hyperplasia; glaucoma; contraindication to scopolamine butylbromide; pregnant and breast-feeding women or women suspected of being pregnant; women are not willing to avoid pregnancy during the duration of study; acute pancreatitis; chronic pancreatitis with an acute exacerbation; post gastrectomy; biliary cannulation using with Rendezvous method; contrast medium allergy; or refusal to provide informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome was the rate of peristalsis suppression of duodenum after treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath